Both first and third-generation CAR T cells targeting MUC1 have been developed, which are able to specifically eliminate HCC cells with high MUC1 expression, while causing minimal damage to normal hepatic cells with low MUC1 expression levels [139]. This evidence concerns the gene MUC1 and hepatocellular carcinoma.